<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151518">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02101489</url>
  </required_header>
  <id_info>
    <org_study_id>LU#206041</org_study_id>
    <nct_id>NCT02101489</nct_id>
  </id_info>
  <brief_title>Does Preoperative 3 D Ultrasound Improve Sling Placement</brief_title>
  <official_title>Does Preoperative 3 D Ultrasound Improve Sling Placement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loyola University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loyola University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This purpose of this study is to study whether the use of a 3D preoperative ultrasound is
      helpful to determine where to place the sling in the mid female urethra.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will assess the effect of 3D preoperative ultrasound in optimization of sling
      placement in the mid female urethra. Women who have chosen to undergo trans-vaginal tape
      sling (TVT) for stress urinary incontinence will be asked to enroll in this randomized
      trial. Ten women will be randomized to receive a preoperative ultrasound before surgery and
      20 women will have our normal pre-operative assessment (which does not include an
      ultrasound) for the treatment of symptomatic stress urinary incontinence. Randomization will
      be performed by the FPMRS study coordinator after a woman has given her informed consent and
      meets the study criteria. Women randomized to receive a preoperative 3-D ultrasound will
      then undergo a 5-minute trans-vaginal ultrasound (BK Flex Focus ultrasound with the 8838
      transvaginal probe). The ultrasound will measure the urethral length and identify the
      mid-urethra region for that patient. The measurement will be placed in the pre-operative
      note. Transvaginal ultrasound is well-tolerated and has no complications associated with it.
       Women who receive our &quot;usual care&quot; will have no pre-operative ultrasound performed. Women
      enrolled in the study will then proceed to surgery as scheduled.

      At the time of surgery the information on the length of the urethra will be used to
      determine the placement of the sling. The surgery will proceed in its usual fashion.

      Using the BK Flex Focus ultrasound with a trans-vaginal (8838) and translabial transducers.
      These transducers are commonly used to assess for pelvic masses, abnormalities or foreign
      body. We will measure and record the length of the urethra and will map out the mid-urethral
      point for sling placement; we will also compare the urethral length measurement obtained by
      preoperative 3D ultrasound to intra-operative urethral length measurement using a Foley
      catheter. Measurements will be recorded from the bladder neck to the urethral opening. A
      representational image will be saved.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>To assess if preoperative 3D ultrasound will optimize sling placement in the mid-urethra</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess if preoperative 3D ultrasound will optimize sling placement in the mid-urethra. Measurement of the urethral length in cm using the 3 D ultrasound and marking the mid-urethral point for sling placement.  We will then compare the mid-point location of the midurethral sling between the group that received a preoperative ultrasound to the group that didn't receive a preoperative ultrasound at 6 weeks for both groups using the 3 D ultrasound. The measurements of the location of the mid-point of the urethral sling will be compared between the two groups (those who received a preoperative ultrasound and those who did not receive it)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the accuracy of 3D ultrasound in measurement of urethral length compared to intraoperative measurement of the urethral length</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assess the accuracy of 3D ultrasound in measurement of urethral length compared to intraoperative measurement of the urethral length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess for migration of mid-urethral slings 6 weeks after surgery</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurement of the urethral length in cm using the 3 D ultrasound and marking the mid-urethral point for sling placement.  We will then compare the mid-point location of the midurethral sling between the group that received a preoperative ultrasound to the group that didn't receive a preoperative ultrasound at 6 weeks for both groups using the 3 D ultrasound. The measurements of the location of the mid-point of the urethral sling will be compared between the two groups (those who received a preoperative ultrasound and those who did not receive it)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stratify the data based on patient race, BMI, prolapse and age</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Stratify the data based on patient race, BMI, prolapse and age</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Preoperative 3D ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 women will have preoperative 3D ultrasound</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No preoperative 3D ultrasound</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>10 women will not have a preoperative 3D ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D ultrasound</intervention_name>
    <description>10 women with preoperative 3D ultrasound and 10 women without preoperative 3D ultrasound.</description>
    <arm_group_label>Preoperative 3D ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidates for TVT

          -  &gt;=18 years of age to participate

        Exclusion Criteria:

          -  Inability to give informed consent

          -  Previous SUI treatment including  TVT, Burch or urethral bulking agents

          -  Previous bladder, urethral malignancies or vaginal/pelvic radiation treatment.

          -  Pregnant women cannot participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth R Mueller, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loyola University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth R Mueller, M.D.</last_name>
    <phone>708-216-0342</phone>
    <email>emuelle@lumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mary J Tulke, R.N.</last_name>
    <phone>708-216-2067</phone>
    <email>mtulke@lumc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loyola University Health System</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth R Mueller, M.D.</last_name>
      <phone>708-216-0342</phone>
      <email>emuelle@lumc.edu</email>
    </contact>
    <investigator>
      <last_name>Elizabeth R Mueller, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aigmueller T, Trutnovsky G, Tamussino K, Kargl J, Wittmann A, Surtov M, Kern P, Frudinger A, Riss P, Bjelic-Radisic V. Ten-year follow-up after the tension-free vaginal tape procedure. Am J Obstet Gynecol. 2011 Nov;205(5):496.e1-5. doi: 10.1016/j.ajog.2011.07.010. Epub 2011 Jul 20.</citation>
    <PMID>21944223</PMID>
  </reference>
  <reference>
    <citation>Olsson I, Abrahamsson AK, Kroon UB. Long-term efficacy of the tension-free vaginal tape procedure for the treatment of urinary incontinence: a retrospective follow-up 11.5 years post-operatively. Int Urogynecol J. 2010 Jun;21(6):679-83. doi: 10.1007/s00192-009-1083-7. Epub 2010 Jan 13.</citation>
    <PMID>20069417</PMID>
  </reference>
  <reference>
    <citation>Nilsson CG, Palva K, Rezapour M, Falconer C. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Aug;19(8):1043-7. doi: 10.1007/s00192-008-0666-z. Epub 2008 Jun 6.</citation>
    <PMID>18535753</PMID>
  </reference>
  <reference>
    <citation>Nilsson CG, Palva K, Aarnio R, Morcos E, Falconer C. Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J. 2013 Aug;24(8):1265-9. doi: 10.1007/s00192-013-2090-2. Epub 2013 Apr 6.</citation>
    <PMID>23563892</PMID>
  </reference>
  <reference>
    <citation>Bjelic-Radisic V, Dorfer M, Greimel E, Frudinger A, Tamussino K, Winter R. Quality of life and continence 1 year after the tension-free vaginal tape operation. Am J Obstet Gynecol. 2006 Dec;195(6):1784-8.</citation>
    <PMID>17132481</PMID>
  </reference>
  <reference>
    <citation>Kociszewski J, Rautenberg O, Perucchini D, Eberhard J, Geissb√ºhler V, Hilgers R, Viereck V. Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourol Urodyn. 2008;27(6):485-90. doi: 10.1002/nau.20556.</citation>
    <PMID>18288705</PMID>
  </reference>
  <reference>
    <citation>Rahn DD, Marinis SI, Schaffer JI, Corton MM. Anatomical path of the tension-free vaginal tape: reassessing current teachings. Am J Obstet Gynecol. 2006 Dec;195(6):1809-13.</citation>
    <PMID>17132484</PMID>
  </reference>
  <reference>
    <citation>McGuire EJ, Lytton B. Pubovaginal sling procedure for stress incontinence. 1978. J Urol. 2002 Feb;167(2 Pt 2):1120-3; discussion 1124.</citation>
    <PMID>11905885</PMID>
  </reference>
  <reference>
    <citation>Barber MD, Chen Z, Lukacz E, Markland A, Wai C, Brubaker L, Nygaard I, Weidner A, Janz NK, Spino C. Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn. 2011 Apr;30(4):541-6. doi: 10.1002/nau.20934. Epub 2011 Feb 22.</citation>
    <PMID>21344495</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 27, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loyola University</investigator_affiliation>
    <investigator_full_name>Elizabeth Mueller</investigator_full_name>
    <investigator_title>M.D., Associate Professor</investigator_title>
  </responsible_party>
  <keyword>SUI</keyword>
  <keyword>TVT</keyword>
  <keyword>Stress urinary incontinence</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
